Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome

Palvella Therapeutics, Inc. · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
basal-cell-carcinomaprevention
bccs in gorlin syndrome patients, gorlin syndrome, basal cell carcinoma, nevoid basal cell carcinoma syndrome, basal cell nevus syndrome bcns, gorlin syndrome alliance, prevention, topical, sirolimus, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 909308
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.